CuraMorbus

Sedentary Time in Children Has Cumulative Effects

Accumulation of inactive time is linked to heart damage independent of body weight and blood pressure, underscoring the importance of reducing sedentary behavior in children for cardiovascular health.

May 2024

Exercising in the Morning for Weight Control

Morning exercise may offer benefits for weight control, possibly due to metabolic and chronobiological factors that influence energy expenditure and metabolism throughout the day.

May 2024

Alcohol Consumption and Ectopic Fat

Higher alcohol intake is associated with greater ectopic fat deposition, including in the heart and other organs, as indicated by a recent study.

May 2024

COVID: WHO Classifies Variant EG.5 as of Interest and Cases Resurface

The World Health Organization (WHO) classifies variant EG.5 of COVID-19 as of interest and urges countries to continue reporting cases, particularly amid a spike in cases during the summer in Europe and the US.

May 2024

Semaglutide for Controlling Overweight and Obesity

Semaglutide is recommended for adults with at least one weight-related comorbidity and a BMI of at least 35 kg/m2, emphasizing its efficacy in controlling overweight and obesity in this population.

May 2024

Oral Health and Survival in Head and Neck Cancer

Better overall survival in head and neck squamous cell carcinoma is associated with maintaining natural teeth and regular dental visits, highlighting the importance of oral health in cancer outcomes.

April 2024

Single Dose Psilocybin for Major Depressive Disorder

Psilocybin demonstrates promise as a potential treatment for major depressive disorder, suggesting its efficacy as a therapeutic option for managing this debilitating condition.

April 2024

Predicting Mortality After Hip Fracture with AI

Certain biomarkers may hold promise for predicting mortality in the years following a hip fracture, potentially aided by artificial intelligence algorithms.

April 2024

Subcutaneous Semaglutide in Heart Failure and Obesity

Weight loss drugs, such as subcutaneous semaglutide, benefit patients with heart failure and obesity, offering potential therapeutic options for improving cardiovascular health and metabolic outcomes in this population.

April 2024

Detection of Cardiovascular Disease in Patients with COPD or Type 2 Diabetes

A proactive diagnostic strategy more than doubled new cardiovascular disease diagnoses in patients with COPD or type 2 diabetes, emphasizing the importance of targeted screening and early detection to improve clinical outcomes in high-risk populations.

April 2024

Allergies Artificial Intelligence Cancer Cardiovascular Child care Covid Diabetes Drugs Exercising Food & Health Hypertension Microbiology Neurology Obstetrics Ophtalmology Oral health Respiratory Skin care Sleep Smoking Surgery Vaccines Women's health